OnKure Therapeutics, Inc. Defensive Interval Ratio

Latest as of June 2026: 543 days

OnKure Therapeutics, Inc. defensive interval ratio. OnKure Therapeutics, Inc. (OKUR) has a Defensive Interval Ratio of 543 days as of June 2026. Defensive assets of $9.88 Million (cash $-, short-term investments $9.88 Million, receivables $-) cover 543 days of daily cash needs of $18.20K/day. See working capital to net assets of OnKure Therapeutics, Inc. to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

543 days
Days of operational coverage

Defensive Assets

$9.88 Million
Cash + ST Investments + Receivables

Daily Cash Need

$18.20K
Current Liabilities ÷ 365

Current Liabilities

$6.64 Million
USD

Defensive Interval Ratio of OnKure Therapeutics, Inc. (2021–2022)

Defensive interval ratio of OnKure Therapeutics, Inc. from 2021 to 2022. This chart shows how OnKure Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2021 to 2022. As of June 2026, the ratio stands at 543 days, meaning defensive assets of $9.88 Million can fund 543 days of operations without new revenue. Check OKUR financial resilience to evaluate the company's liquid asset resilience ratio.

OnKure Therapeutics, Inc. Defensive Interval Ratio by Year (2021–2022)

OnKure Therapeutics, Inc. defensive interval ratio by year from 2021 to 2022. The table below presents the year-by-year Defensive Interval Ratio for OnKure Therapeutics, Inc. from 2021 to 2022, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of OnKure Therapeutics, Inc..

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2022 5351 days $81.25 Million $15.18K/day $- $81.25 Million ▲ +3997 days
2021 1354 days $23.01 Million $16.99K/day $- $23.01 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)